144 related articles for article (PubMed ID: 30609169)
1. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Tsujinaka A; Takai Y; Inoue Y; Tanito M
Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
[No Abstract] [Full Text] [Related]
2. Corneal sterile infiltration induced by topical use of ocular hypotensive agent.
Manabe Y; Sawada A; Mochizuki K
Eur J Ophthalmol; 2020 Sep; 30(5):NP23-NP25. PubMed ID: 31096781
[TBL] [Abstract][Full Text] [Related]
3. Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use.
Maruyama Y; Ikeda Y; Yokoi N; Mori K; Kato H; Ueno M; Kinoshita S; Sotozono C
Cornea; 2017 Dec; 36(12):1567-1569. PubMed ID: 28938378
[TBL] [Abstract][Full Text] [Related]
4. OTC brimonidine (Lumify) for ocular redness.
Med Lett Drugs Ther; 2018 Oct; 60(1558):176. PubMed ID: 30335046
[No Abstract] [Full Text] [Related]
5. Bilateral granulomatous uveitis in an elderly female.
Kattige J; Konana VK; Babu K
Indian J Ophthalmol; 2019 Sep; 67(9):1391. PubMed ID: 31436179
[No Abstract] [Full Text] [Related]
6. Allergic contact dermatitis to topical brimonidine.
Rajagopalan A; Rajagopalan B
Australas J Dermatol; 2015 Aug; 56(3):235. PubMed ID: 26201375
[No Abstract] [Full Text] [Related]
7. Interstitial Keratitis with Lipid Keratopathy Mimicking Corneal Opacity Induced by Brimonidine Tartrate Eye Drops.
Kasuya Y; Sano I; Makino S
Klin Monbl Augenheilkd; 2020 Dec; 237(12):1466-1467. PubMed ID: 33285590
[No Abstract] [Full Text] [Related]
8. Corneal vascularization and opacification during long-term use of dipivefrin.
Salminen L; Krootila K; Helin H; Hakala T
J Ocul Pharmacol Ther; 1995; 11(1):37-40. PubMed ID: 8535955
[TBL] [Abstract][Full Text] [Related]
9. [Brimonidine (Mirvaso), dermal use].
Van Genechten D
J Pharm Belg; 2015 Jun; (2):45-6. PubMed ID: 26466509
[No Abstract] [Full Text] [Related]
10. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
[TBL] [Abstract][Full Text] [Related]
11. Brimonidine Induced Anterior Uveitis.
Beltz J; Zamir E
Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
[TBL] [Abstract][Full Text] [Related]
12. Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
Clemente-Tomás R; Arciniegas-Perasso CA; Hervás-Hernandis JM; García-Ibor F; Ruiz-Del Río N; Duch-Samper AM
Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):511-514. PubMed ID: 29910082
[TBL] [Abstract][Full Text] [Related]
13. Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.
Wiegell SR; Johansen UB; Wulf HC
Acta Derm Venereol; 2019 Feb; 99(2):242-243. PubMed ID: 30250962
[No Abstract] [Full Text] [Related]
14. Short-term effect of topical brimonidine tartrate on intrastromal corneal pressure in rabbits.
Bolívar G; Teus MA; Hernández-Verdejo JL
J Refract Surg; 2010 Jul; 26(7):533-5. PubMed ID: 20349857
[TBL] [Abstract][Full Text] [Related]
15. [Corneal neovascularization after chemical burn].
Siham B; Nabil A; Houda A
J Fr Ophtalmol; 2018 Sep; 41(7):685. PubMed ID: 30193897
[No Abstract] [Full Text] [Related]
16. The Results of Preoperative Use of Topical Brimonidine in Strabismus Surgery.
Ucar F; Cetinkaya S
J Ocul Pharmacol Ther; 2021 May; 37(4):230-235. PubMed ID: 33684337
[No Abstract] [Full Text] [Related]
17. Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients.
Barwal I; Kumar R; Dada T; Yadav SC
Microsc Microanal; 2019 Dec; 25(6):1352-1366. PubMed ID: 31018876
[TBL] [Abstract][Full Text] [Related]
18. A review of neuropsychiatric adverse events from topical ophthalmic brimonidine.
Cimolai N
Hum Exp Toxicol; 2020 Oct; 39(10):1279-1290. PubMed ID: 32347114
[TBL] [Abstract][Full Text] [Related]
19. Deep stromal opacity after corneal cross-linking.
Kato N; Konomi K; Saiki M; Negishi K; Takeuchi M; Shimazaki J; Tsubota K
Cornea; 2013 Jul; 32(7):895-8. PubMed ID: 23407323
[TBL] [Abstract][Full Text] [Related]
20. Visualization of corneal vascularization in peripheral hypertrophic subepithelial corneal opacification with OCT angiography.
Riedl JC; Wasielica-Poslednik J; Weyer-Elberich V; Vossmerbaeumer U; Pfeiffer N; Lisch W; Gericke A
Acta Ophthalmol; 2018 Dec; 96(8):e974-e978. PubMed ID: 29671946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
